POBA CIO (second from left), Teachers Pension CIO (center), SEMA CIO (second from right), Hyundai Marine & Fire Insurance executive director (far right)
South Korea s Public Officials Benefit Association (POBA) has earmarked over 1 trillion won ($900 million) for new investments in overseas real estate this year, for which it will expand separately managed accounts (SMAs) and co-investment platforms because they ease the burden of due diligence, said its senior officials.
By asset type, the $15 billion retirement fund for South Korea’s local government employees is zooming in on residential, logistics and infrastructure properties in public-private partnerships (PPPs), its Chief Investment Officer Jang Dong-hun told a CIO panel session of the ASK Summit 2021 held in Seoul on May 12.
CIO PANEL DISCUSSION
Chief investment officers of the Public Officials Benefit Association (POBA: Jang Dong-hun), the Teachers Pension (Lee Kyu-hong) and the Korea Scientists and Engineers Mutual-Aid Association (Huh Sung-moo) will participate in a CIO panel discussion on May 12. Hyundai Marine & Fire Insurance Co. Executive Director Jeon Kyung Chul will accompany them to the discussion.
POBA CIO Jang Dong-hun (second from left), Teachers Pension CIO Lee Kyu-hong (center) and SEMA CIO Huh Sung-moo (far right)
LP PANEL SESSIONS
For the hedge fund segment, three senior managers will share their views in a group discussion: Kim Jun Geun, NPS senior portfolio manager of the private equity and venture capital investment division; KIC s senior director of the alternative investment division s absolute returns group Yoon Sunghyun; and Korea Post s insurance arm Deputy Director of hedge fund investment Su Jin Lee..
As Korea Resumes Short-Selling, Stocks That Rose Most Take Hit
May 03 2021, 2:46 PM
May 03 2021, 11:27 AM
May 03 2021, 2:46 PM
(Bloomberg) Investors rushed to sell shares of some Korean biopharmaceutical companies which surged last year as the nation lifted the worldâs longest pandemic-imposed short-selling ban on Monday.
(Bloomberg) Investors rushed to sell shares of some Korean biopharmaceutical companies which surged last year as the nation lifted the worldâs longest pandemic-imposed short-selling ban on Monday.
The health-care sector slumped 4.9%, the biggest loser among Kospi 200âs sub-gauges. The group rallied 67% in 2020, the best performer of all. Drug developer Celltrion Inc. tanked 6.2%. HLB Inc. finished 4.2% lower as investors preemptively sold their holdings in the health-care company, according to Eugene Investment & Securities Co. analyst Han Byung-Hwa.